Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $2.23 billion. The enterprise value is $1.95 billion.
| Market Cap | 2.23B |
| Enterprise Value | 1.95B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 279.83 million shares outstanding. The number of shares has increased by 24.58% in one year.
| Shares Outstanding | 279.83M |
| Shares Change (YoY) | +24.58% |
| Shares Change (QoQ) | +3.92% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 89.46% |
| Float | 207.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,169.89 |
| Forward PS | 8.02 |
| PB Ratio | 3.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,023.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.63 |
| Quick Ratio | 4.36 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.50% and return on invested capital (ROIC) is -61.15%.
| Return on Equity (ROE) | -71.50% |
| Return on Assets (ROA) | -55.20% |
| Return on Capital (ROIC) | -61.15% |
| Revenue Per Employee | $3,418 |
| Profits Per Employee | -$807,259 |
| Employee Count | 557 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.05% in the last 52 weeks. The beta is 0.63, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +2.05% |
| 50-Day Moving Average | 8.96 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 43.95 |
| Average Volume (20 Days) | 7,288,394 |
Short Selling Information
The latest short interest is 56.42 million, so 20.16% of the outstanding shares have been sold short.
| Short Interest | 56.42M |
| Short Previous Month | 54.63M |
| Short % of Shares Out | 20.16% |
| Short % of Float | 27.21% |
| Short Ratio (days to cover) | 6.97 |
Income Statement
In the last 12 months, IOVA had revenue of $1.90 million and -$449.64 million in losses. Loss per share was -$1.80.
| Revenue | 1.90M |
| Gross Profit | -16.11M |
| Operating Income | -467.43M |
| Pretax Income | -454.53M |
| Net Income | -449.64M |
| EBITDA | -417.19M |
| EBIT | -454.53M |
| Loss Per Share | -$1.80 |
Balance Sheet
The company has $362.63 million in cash and $84.37 million in debt, giving a net cash position of $278.26 million or $0.99 per share.
| Cash & Cash Equivalents | 362.63M |
| Total Debt | 84.37M |
| Net Cash | 278.26M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 680.02M |
| Book Value Per Share | 2.43 |
| Working Capital | 302.32M |
Cash Flow
In the last 12 months, operating cash flow was -$384.28 million and capital expenditures -$20.80 million, giving a free cash flow of -$405.08 million.
| Operating Cash Flow | -384.28M |
| Capital Expenditures | -20.80M |
| Free Cash Flow | -405.08M |
| FCF Per Share | -$1.52 |
Margins
Gross margin is -846.22%, with operating and profit margins of -24,549.63% and -23,615.70%.
| Gross Margin | -846.22% |
| Operating Margin | -24,549.63% |
| Pretax Margin | -23,872.37% |
| Profit Margin | -23,615.70% |
| EBITDA Margin | -21,911.40% |
| EBIT Margin | -23,872.37% |
| FCF Margin | -21,275.26% |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.58% |
| Shareholder Yield | -24.58% |
| Earnings Yield | -20.19% |
| FCF Yield | -18.19% |
Analyst Forecast
The average price target for IOVA is $25.70, which is 222.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.70 |
| Price Target Difference | 222.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 311.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of 2.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.32 |
| Piotroski F-Score | 1 |